Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the survival, recovered body weight loss, and decreased proteinuria and serum creatinine levels in ADR-treated mice. MSCs also prevented podocyte damage and renal fibrosis by decreasing the expression of fibronectin, collagen 1α1, and α-smooth muscle actin. From a mechanistic perspective, MSCs inhibited renal inflammation by lowering the expression of CCL4, CCL7, CCL19, IFN-α/β, TGF-β, TNF-α, and chitinase 3-like 1. In summary, our data demonstrate that MSCs improve renal functions by inhibiting renal inflammation in ADR-induced nephropathy.
Abstract
Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the survival, recovered body weight loss, and decreased proteinuria and serum creatinine levels in ADR-treated mice. MSCs also prevented podocyte damage and renal fibrosis by decreasing the expression of fibronectin, collagen 1α1, and α-smooth muscle actin. From a mechanistic perspective, MSCs inhibited renal inflammation by lowering the expression of CCL4, CCL7, CCL19, IFN-α/β, TGF-β, TNF-α, and chitinase 3-like 1. In summary, our data demonstrate that MSCs improve renal functions by inhibiting renal inflammation in ADR-induced nephropathy.
참고문헌 (35)
- Lee VW, "Adriamycin nephropathy: a model of focal segmental glomerulosclerosis", Nephrology (Carlton), 16, pp.30~38 (2011)
- Nogueira A, "Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies", In Vivo, 31, pp.1~22 (2017)
- Zhang H, "AF1q contributes to Adriamycin-induced podocyte injury by activating Wnt", β-catenin signaling, 2017, pp.42, 794~803
- Zoja C, "Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in Adriamycin-induced nephropathy", Am J Physiol Renal Physiol, 303, pp.F1370~F1381 (2012)
- Huuskes BM, "Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy", FASEB J, 29, pp.540~553 (2015)
- Mahajan D, "CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease", J Am Soc Nephrol, 17, pp.2731~2741 (2006)
- Mehdi Najar, "Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review", Immune Network, 17(2), pp.89~109 (2017), 대한면역학회[DOI]
- Ma H, "The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats", Cytotherapy, 15, pp.703~711 (2013)
- Fitzsimmons RE, "Mesenchymal stromal", stem cells in regenerative medicine and tissue engineering, 2018, pp.2018, 8031718~
- Ma H, "Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis", Am J Med Sci, 346, pp.486~493 (2013)
- Yokote S, "Effect of adipose-derived mesenchymal stem cell transplantation on vascular calcification in rats with adenine-induced kidney disease", Sci Rep, 7, pp.14036~ (2017)
- Lange C, "Administered mesenchymal stem cells enhance recovery from ischemia", reperfusion-induced acute renal failure in rats, 2005, pp.68, 1613~1617
- Morigi M, "Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure", J Am Soc Nephrol, 15, pp.1794~1804 (2004)
- Bi B, "Stromal cells protect against acute tubular injury via an endocrine effect", J Am Soc Nephrol, 18, pp.2486~2496 (2007)
- Tögel F, "Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury", Am J Physiol Renal Physiol, 292, pp.F1626~F1635 (2007)
- Lee HK, "CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms", Sci Rep, 7, pp.41258~ (2017)
- Kim DH, "Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis", Nat Commun, 9, pp.503~ (2018)
- Wang Y, "Progressive Adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events", Kidney Int, 58, pp.1797~1804 (2000)
- 이유호, "Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients", Immune Network, 18(5), pp.1~13 (2018), 대한면역학회[DOI]
- Peng X, "Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury", Exp Biol Med (Maywood), 238, pp.960~970 (2013)
- Uehara Y, "Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats", J Hypertens, 9, pp.719~728 (1991)
- Murakami A, "A novel method for isolating podocytes using magnetic activated cell sorting", Nephrol Dial Transplant, 25, pp.3884~3890 (2010)
- Lee HK, "Effect of a combination of prednisone or mycophenolate mofetil and mesenchymal stem cells on lupus symptoms in MRL.Faslpr mice", Stem Cells Int, 2018, pp.4273107~ (2018)
- Lee JH, "CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL.Faslpr mice", Lupus, 27, pp.1854~1859 (2018)
- Montgomery TA, "Breast regression protein-39", chitinase 3-like 1 promotes renal fibrosis after kidney injury via activation of myofibroblasts, 2017, pp.28, 3218~3226
- Semedo P, "Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model", Stem Cells, 27, pp.3063~3073 (2009)
- Wise AF, "Mesenchymal stem cells in kidney inflammation and repair", Nephrology (Carlton), 17, pp.1~10 (2012)
- Wu HJ, "Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis", PLoS One, 9, pp.e90883~ (2014)
- Lee CG, "Role of chitin and chitinase", chitinase-like proteins in inflammation, tissue remodeling, and injury, 2011, pp.73, 479~501
- Nielsen TL, "YKL-40 in patients with end-stage renal disease receiving haemodialysis", Biomarkers, 23, pp.357~363 (2018)
- Nadkarni GN, "Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: the ACCORD trial", Clin J Am Soc Nephrol, 11, pp.1343~1352 (2016)
- Ziatabar S, "Chitin, chitinases, and chitin lectins: emerging roles in human pathophysiology", Pathophysiology, 25, pp.253~262 (2018)
- Wang S, "Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model", Biol Blood Marrow Transplant, 19, pp.538~546 (2013)
- Zhong F, "Role of C", EBP-α in Adriamycin-induced podocyte injury, 2016, pp.6, 33520~
- Szalay CI, "Oxidative", nitrative stress and inflammation drive progression of doxorubicin-induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis-resistant rat strain, 2015, pp.10, e0127090~
